Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction

American heart journal

Volumn 143, Issue 2, 2002, Pages 294-300

  Pilote, Louise ^a   Green, Laurence ^a   Joseph, Lawrence ^a   Richard, Hugues ^a   Eisenberg, Mark J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; MACROLIDE; TETRACYCLINE DERIVATIVE;

AGED; ARTICLE; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CONFIDENCE INTERVAL; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; FEMALE; HEART INFARCTION; HUMAN; MALE; MICROBIOLOGY; MORTALITY; PROGNOSIS; SURVIVAL RATE;

4-QUINOLONES; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CONFIDENCE INTERVALS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MACROLIDES; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; SURVIVAL RATE; TETRACYCLINES;

EID: 0036481726     PISSN: None     EISSN: 10976744     Source Type: Journal    
DOI: 10.1067/mhj.2002.120296     Document Type: Article

References (23)

1. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
2. JB Muhlestein EH Hammond JF Carlquist E Radicke MJ Thomson LA Karagounis Increased incidence of Chlamydia species with the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease J Am Coll Cardiol 27 1996 1555 1561
3. JA Ramirez the Chlamydia Pneumoniae/Atherosclerosis Study Group Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis Ann Intern Med 125 1996 979 982
4. CC Kuo A Shor L Campbell H Fukushi DL Patton JT. Grayston Demonstration of Chlamydia pneumoniae in atherosclerosis lesions of coronary arteries J Infect Dis 167 1993 841 849
5. LA Campbell ER O'Brien AL Cappuccio CC Kuo SP Wang D Stewart Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues J Infect Dis 172 1995 585 588
6. Y Wong M Thomas V Tsang PJ Gallagher ME. Ward The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery J Am Coll Cardiol 33 1999 152 156
7. F Blasi F Denti M Erba R Cosentini R Raccanelli A Rinaldi Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms J Clin Microbiol 34 1996 2766 2769
8. DH Thom JT Grayston D Siscovick S-P Way NS Weiss JR. Daling Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease JAMA 268 1992 68 72
9. DH Thom S-P Wang JT Grayston DS Siscovick DK Stewart RA Kronmal Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary disease Arterioscler Thromb 11 1991 547 551
10. P Saikku K Mattila MS Nieminen JK Huttunen M Leinonen CR. Ekman Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 1988 983 986
11. E Linnanmaki M Leinonen K Mattila MS Nieminen V Valtonen P. Saikku Chlamydia pneumoniae – specific circulating immune complexes in patients with chronic coronary heart disease Circulation 87 1993 1130 1134
12. SL Melnick E Shahar AR Folsom JT Grayston PD Sorlie S-P Want for the Atherosclerosis Risk in Communities ARIC Study Investigators Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis Am J Med 95 1993 499 504
13. P Saikku M Leinonen L Tendanen E Linnanmäki CR Ekman V Manninen Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med 116 1992 273 278
14. H Mietinnen S Lehto P Saikku SM Haffner T Ronnemaa K Pyorala Association of Chlamydia pneumoniae and acute coronary heart disease in non-insulin dependent diabetic and non-diabetic subjects in Finland Eur Heart J 17 1996 682 688
15. FJ Nieto AR Folsom PD Sorlie JT Grayston S-P Wang LE Chambless for the Atherosclerosis Risk in Communities ARIC Study Investigators Chlamydia pneumoniae infection and incident coronary heart disease Am J Epidemiol 150 1999 149 156
16. PM Ridker RB Kundsin MJ Stampfer S Poulin CH. Hennekens Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction Circulation 99 1999 1161 1164
17. CR Meier LE Derby SS Jick C Vasilakis H. Jick Antibiotics and risk of subsequent first-time acute myocardial infarction JAMA 281 1999 427 431
18. AR. Folsom Antibiotics for prevention of myocardial infarction? Not yet! JAMA 281 1999 461 462
19. E. Gurfinkel G Bozovich A Daroca E Beck B Mautner for the ROXIS Study Group Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study Lancet 350 1997 404 407
20. S Gupta AJ. Camm Chlamydia pneumoniae and coronary heart disease: coincidence, association, or causation? Br Med J 314 1997 1778 1779
21. S Gupta EW Leathham D Carrington MA Mendall JC Kaski AJ. Camm Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction Circulation 96 1997 404 407
22. JB Muhlestien JL Anderson JF Carlquist K Salunkhe BD Horne RR Pearson Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study Circulation 102 2000 1755 1760
23. JL Mehta TGP Saldeen K. Rand Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease J Am Coll Cardiol 31 1998 1217 1225